CureVac N.V. (CVAC)
USD 3.26
(2.04%)
USD 3.26
(2.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -360.92 Million EUR | 20.45% |
| 2022 | -453.71 Million EUR | 42.02% |
| 2021 | -782.57 Million EUR | 39.45% |
| 2020 | -1.29 Billion EUR | -2766.94% |
| 2019 | 48.46 Million EUR | 327.5% |
| 2018 | -21.3 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -259.51 Million EUR | 28.1% |
| 2024 Q2 | -163.57 Million EUR | 37.0% |
| 2023 Q2 | -497.44 Million EUR | 13.69% |
| 2023 Q1 | -576.37 Million USD | -27.04% |
| 2023 FY | -360.92 Million EUR | 20.45% |
| 2023 Q4 | -360.92 Million EUR | 14.48% |
| 2023 Q3 | -422.03 Million EUR | 15.16% |
| 2022 Q2 | -533.35 Million EUR | 13.63% |
| 2022 FY | -453.71 Million EUR | 42.02% |
| 2022 Q4 | -453.71 Million EUR | 9.19% |
| 2022 Q3 | -499.6 Million EUR | 6.33% |
| 2022 Q1 | -617.54 Million EUR | 21.09% |
| 2021 Q2 | -1.32 Billion EUR | -200.32% |
| 2021 FY | -782.57 Million EUR | 39.45% |
| 2021 Q1 | 1.32 Billion EUR | 202.33% |
| 2021 Q4 | -782.57 Million EUR | 22.09% |
| 2021 Q3 | -1 Billion EUR | 24.3% |
| 2020 Q4 | -1.29 Billion EUR | -49.99% |
| 2020 Q2 | 44.89 Million EUR | -19.85% |
| 2020 Q3 | -861.75 Million EUR | -2019.62% |
| 2020 Q1 | 56.01 Million EUR | 15.57% |
| 2020 FY | -1.29 Billion EUR | -2766.94% |
| 2019 Q1 | 60.63 Million EUR | 0.0% |
| 2019 FY | 48.46 Million EUR | 327.5% |
| 2019 Q4 | 48.46 Million EUR | 0.0% |
| 2018 FY | -21.3 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -23.67 Million USD | -1424.371% |
| IO Biotech, Inc. | -140.69 Million USD | -156.523% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5853.898% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -48.919% |
| Agenus Inc. | 274.13 Million USD | 231.659% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -548.983% |
| GlycoMimetics, Inc. | -40.98 Million USD | -780.64% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4651.518% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2826.228% |
| Novavax, Inc. | -298.29 Million USD | -20.997% |
| AlloVir, Inc. | -62.69 Million USD | -475.712% |
| MiMedx Group, Inc. | -33.9 Million USD | -964.645% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3433.634% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1098.051% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5334.9% |
| Chimerix, Inc. | -25.51 Million USD | -1314.45% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5279.698% |
| CRISPR Therapeutics AG | -150.84 Million USD | -139.269% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 4.312% |
| Precision BioSciences, Inc. | -85.41 Million USD | -322.58% |
| Dyadic International, Inc. | -6.37 Million USD | -5558.823% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1787.882% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2165.269% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4808.745% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4808.745% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 689.199% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 119.301% |
| Aptorum Group Limited | 1.35 Million USD | 26696.396% |
| Ardelyx, Inc. | 34.51 Million USD | 1145.797% |
| Bicycle Therapeutics plc | -481.46 Million USD | 25.036% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -226.52% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2663.208% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4124.721% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1961.277% |
| GT Biopharma, Inc. | -1.02 Million USD | -35250.179% |
| Alkermes plc | -166.73 Million USD | -116.461% |
| Innoviva, Inc. | 255.56 Million USD | 241.228% |
| Jaguar Health, Inc. | 29.39 Million USD | 1328.013% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -13.963% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2049.773% |
| ContextLogic Inc. | -232 Million USD | -55.571% |
| Lantern Pharma Inc. | -21.7 Million USD | -1562.999% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2188.93% |
| MEI Pharma, Inc. | -3.7 Million USD | -9641.574% |
| AbCellera Biologics Inc. | -55.94 Million USD | -545.201% |
| NextCure, Inc. | -6.47 Million USD | -5472.415% |
| Onconetix, Inc. | 5.33 Million USD | 6869.757% |
| Opthea Limited | 28.15 Million USD | 1381.811% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3067.339% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7252.319% |
| Vaxcyte, Inc. | -368.22 Million USD | 1.983% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1003.447% |
| Pharming Group N.V. | 109.8 Million USD | 428.7% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1974.76% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8532.835% |
| PureTech Health plc | -167.19 Million USD | -115.868% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3640.219% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1398.62% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -105.972% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15477.088% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1848.856% |
| Seer, Inc. | -4.24 Million USD | -8412.39% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4983.455% |
| Acelyrin, Inc. | -216.9 Million USD | -66.399% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6333.3% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -20835.344% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1140.911% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5205.385% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -179.54% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1848.856% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -366.005% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 57572.186% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1401.541% |
| ChromaDex Corporation | -24.04 Million USD | -1400.854% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -134.145% |
| Incyte Corporation | -3.17 Billion USD | 88.633% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -546.079% |
| ESSA Pharma Inc. | -33.62 Million USD | -973.493% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -614.689% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6059.135% |
| Senti Biosciences, Inc. | 1.74 Million USD | 20842.835% |
| ImmuCell Corporation | 10.99 Million USD | 3383.957% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6862.701% |
| Precigen, Inc. | -481 Thousand USD | -74936.451% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2504.831% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5558.024% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -95.51% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 323.149% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 361860.995% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 425.539% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -208.362% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1084.916% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2984.864% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -114.539% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 685.291% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -432.472% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -169.189% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1150.088% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -479000.177% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1069.481% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4304.291% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11434.78% |
| Soligenix, Inc. | -4.95 Million USD | -7189.069% |
| Century Therapeutics, Inc. | 847 Thousand USD | 42712.199% |
| Kura Oncology, Inc. | -20.11 Million USD | -1694.042% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -781.897% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4197.753% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 19912.61% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11189.5% |
| Autolus Therapeutics plc | -186.59 Million USD | -93.423% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -632.041% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -30.868% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1153.243% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 319.584% |
| GRI Bio, Inc. | -1.79 Million USD | -20018.469% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3917.85% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -985.261% |
| IGM Biosciences, Inc. | -72.6 Million USD | -397.101% |
| INmune Bio, Inc. | -25.41 Million USD | -1320.351% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 339.101% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -612.46% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2121.165% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12410.731% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1049.429% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -776.351% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1231.96% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 195.495% |
| Verastem, Inc. | -37.27 Million USD | -868.199% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3878.015% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -595.934% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2284.706% |
| Histogen Inc. | -7.48 Million USD | -4720.694% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1570.423% |
| Surrozen, Inc. | -32.66 Million USD | -1004.964% |
| Organovo Holdings, Inc. | -1.5 Million USD | -23849.922% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8486.329% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2003.594% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 13896.84% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8784.44% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4206.394% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -730.821% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2376.016% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -13.932% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -49885.504% |
| Apollomics, Inc. | -27.39 Million USD | -1217.486% |
| Amarin Corporation plc | -191.04 Million USD | -88.927% |
| Mesoblast Limited | 55.96 Million USD | 744.936% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2374.803% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1327.034% |
| Synaptogenix, Inc. | -28.66 Million USD | -1159.269% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -38460.398% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 840.633% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41766.365% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4867.263% |
| Exelixis, Inc. | -73.05 Million USD | -394.08% |
| Better Therapeutics, Inc. | -860 Thousand USD | -41868.061% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1403.041% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -49.531% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 49134.37% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4752.363% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 28881.924% |
| Gritstone bio, Inc. | 39.49 Million USD | 1013.966% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -329.157% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13612.239% |
| Avid Bioservices, Inc. | 169.72 Million USD | 312.649% |
| Insmed Incorporated | 721.62 Million USD | 150.016% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3848.202% |
| MediWound Ltd. | -5.32 Million USD | -6681.761% |
| OmniAb, Inc. | 9.2 Million USD | 4021.823% |
| Alector, Inc. | -35.63 Million USD | -912.783% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 519.822% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7223.972% |
| Zai Lab Limited | -775 Million USD | 53.429% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 205.982% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1576.773% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -337.591% |
| Immunic, Inc. | -45.34 Million USD | -696.042% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -86.8% |
| Veracyte, Inc. | -203.82 Million USD | -77.077% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 156.545% |
| FibroGen, Inc. | 56.76 Million USD | 735.801% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4153.064% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12666.709% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -17333.075% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 107.863% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10702.913% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -117.472% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2120.632% |
| Galecto, Inc. | -21.21 Million USD | -1601.194% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1417.449% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 122.998% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1374.85% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3036.572% |
| XBiotech Inc. | -200.02 Million USD | -80.442% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -329.157% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8070.966% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -923.524% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -367.411% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6442.037% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -111.792% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -290.722% |
| Vaxxinity, Inc. | 10.13 Million USD | 3662.232% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 149.021% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3251.972% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -447.221% |
| NexImmune, Inc. | -3.13 Million USD | -11417.755% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10353.504% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2288.423% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1231.828% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3920.98% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -289625.328% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -789.592% |
| Ainos, Inc. | 4.07 Million USD | 8950.704% |
| Pluri Inc. | 22.82 Million USD | 1680.995% |
| Prothena Corporation plc | -608.34 Million USD | 40.671% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -203.922% |
| Celularity Inc. | 65.19 Million USD | 653.651% |
| Rallybio Corporation | -24.1 Million USD | -1397.491% |
| Cue Biopharma, Inc. | -33.81 Million USD | -967.226% |
| MeiraGTx Holdings plc | -40.3 Million USD | -795.552% |
| Omeros Corporation | 331.17 Million USD | 208.983% |
| Humacyte, Inc. | -22.48 Million USD | -1505.111% |
| Immunocore Holdings plc | -358.59 Million USD | -0.65% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1368.669% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1068.005% |
| Blueprint Medicines Corporation | 702.83 Million USD | 151.353% |
| CalciMedica, Inc. | -5.53 Million USD | -6426.679% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -91.757% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -801.479% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -985.392% |
| Pulmatrix, Inc. | -10.41 Million USD | -3364.772% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5938.57% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -846.267% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -223.985% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -502.104% |
| Cytokinetics, Incorporated | 642.37 Million USD | 156.186% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -6098.271% |
| Nutriband Inc. | -251.65 Thousand USD | -143319.546% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -957.843% |
| Vor Biopharma Inc. | 4.3 Million USD | 8493.612% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.02% |
| Evogene Ltd. | -19.63 Million USD | -1738.267% |
| ProKidney Corp. | -56.23 Million USD | -541.805% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -641.546% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3807.308% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 126.463% |
| CorMedix Inc. | -43.05 Million USD | -738.338% |
| BioLineRx Ltd. | 7.33 Million USD | 5019.92% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1214.128% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 882.121% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1163.833% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 16281.154% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1481.896% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2135.102% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -380.759% |
| MediciNova, Inc. | -50.78 Million USD | -610.714% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -357.998% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1604369.113% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5493.496% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -80.624% |
| Biomea Fusion, Inc. | -166.57 Million USD | -116.681% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -101.662% |
| Mereo BioPharma Group plc | -51.46 Million USD | -601.248% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -280.546% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -22.864% |
| Absci Corporation | -72.59 Million USD | -397.156% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8004.628% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -53.954% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -283.103% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -277.158% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -823.721% |
| Allakos Inc. | -24.97 Million USD | -1345.146% |
| Imunon, Inc. | -4.21 Million USD | -8465.211% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2348.279% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -166.562% |
| BioAtla, Inc. | -109.01 Million USD | -231.091% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 49134.37% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -38337.202% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3116.257% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1602.237% |
| XOMA Corporation | -29 Million USD | -1144.57% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2079.501% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3903.165% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4745.286% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -189.584% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -73.385% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -341.342% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -289.083% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -41907.92% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9286.875% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22339.667% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 126.137% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30277.468% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8319.661% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 418.049% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 501649.883% |
| Orgenesis Inc. | 21.78 Million USD | 1756.837% |
| Entera Bio Ltd. | -10.62 Million USD | -3295.666% |
| GH Research PLC | -78.07 Million USD | -362.268% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1519.371% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1253.859% |
| Xencor, Inc. | 29.64 Million USD | 1317.532% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -18222.831% |
| Replimune Group, Inc. | 1.41 Million USD | 25661.284% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -147271.8% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -185.504% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30277.468% |
| Portage Biotech Inc. | -4.98 Million USD | -7146.041% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1604369.113% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -445.848% |
| OncoCyte Corporation | -6.56 Million USD | -5399.396% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 40318.42% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7822.599% |
| Purple Biotech Ltd. | -14.13 Million USD | -2452.874% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1419.302% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5414.52% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2062.244% |
| HilleVax, Inc. | -165.48 Million USD | -118.102% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14120.856% |
| Tharimmune, Inc. | -10.93 Million USD | -3200.537% |
| Genprex, Inc. | -6.73 Million USD | -5256.86% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 2.137% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -308.01% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -25661.979% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -10781.254% |
| OKYO Pharma Limited | -826.84 Thousand USD | -43550.747% |
| Savara Inc. | 153 Thousand USD | 235998.907% |
| Curis, Inc. | -23.88 Million USD | -1410.97% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6897.51% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -46410.277% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5713.874% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 30557.834% |
| BeiGene, Ltd. | -2.25 Billion USD | 83.981% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 3025.196% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 40.657% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -94.479% |
| Erasca, Inc. | -37.21 Million USD | -869.812% |
| bluebird bio, Inc. | 108.57 Million USD | 432.433% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27924.481% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 195.294% |
| DBV Technologies S.A. | -126.98 Million USD | -184.225% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27924.481% |
| Moderna, Inc. | -2.9 Billion USD | 87.584% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3386.528% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3220.991% |
| Molecular Templates, Inc. | 707 Thousand USD | 51150.258% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1050.506% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 204.131% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -339.82% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -293.465% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1018.385% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -949.934% |
| MacroGenics, Inc. | -66.98 Million USD | -438.815% |
| RenovoRx, Inc. | -1.17 Million USD | -30669.423% |
| Adicet Bio, Inc. | -138.78 Million USD | -160.057% |
| Prime Medicine, Inc. | -27.94 Million USD | -1191.741% |
| Aditxt, Inc. | 18.12 Million USD | 2091.764% |
| Adagene Inc. | -87.62 Million USD | -311.886% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8564.784% |
| Quantum-Si incorporated | -118.55 Million USD | -204.432% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1102.431% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4728.957% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -644.038% |
| SciSparc Ltd. | -2.06 Million USD | -17378.224% |
| Vericel Corporation | 1.27 Million USD | 28363.534% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2909.793% |
| Minerva Neurosciences, Inc. | 41 Million USD | 980.214% |
| Generation Bio Co. | 31.44 Million USD | 1247.689% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -105.815% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1067.174% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 409.56% |
| Invivyd, Inc. | -198.47 Million USD | -81.848% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -299.829% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -14953.055% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -409.854% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5188.283% |
| 2seventy bio, Inc. | 181.71 Million USD | 298.622% |
| ADMA Biologics, Inc. | 90.06 Million USD | 500.734% |
| Clene Inc. | 3.34 Million USD | 10906.148% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3873.766% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1577.864% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5493.496% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -4.882% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1288.191% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 303.148% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8721.2% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7315.62% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6828.879% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -176.987% |
| Evaxion Biotech A/S | 5.28 Million USD | 6926.858% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -220.629% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -174.943% |
| Trevena, Inc. | 2.25 Million USD | 16084.293% |
| Surrozen, Inc. | -32.66 Million USD | -1004.964% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -600.69% |
| Cingulate Inc. | 3.08 Million USD | 11808.156% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12188.911% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5121.919% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3784.582% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -355.007% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -174.568% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -241.973% |
| Clearmind Medicine Inc. | -3.94 Million USD | -9054.414% |
| Kronos Bio, Inc. | -36.05 Million USD | -901.069% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3935.958% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24852.667% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -565.227% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2603.574% |
| ImmunityBio, Inc. | 618.22 Million USD | 158.381% |
| Korro Bio, Inc. | -132.94 Million USD | -171.489% |
| Kineta, Inc. | -4.54 Million USD | -7848.146% |
| BioVie Inc. | -17.73 Million USD | -1935.406% |
| Codexis, Inc. | -43.27 Million USD | -734.104% |
| Celularity Inc. | 65.19 Million USD | 653.651% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11289.25% |
| Celcuity Inc. | 6.78 Million USD | 5420.629% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10626.043% |
| Cibus, Inc. | -8.07 Million USD | -4368.004% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8434.531% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7997.71% |
| IN8bio, Inc. | -16.38 Million USD | -2102.241% |
| Kodiak Sciences Inc. | -103.87 Million USD | -247.461% |
| Annexon, Inc. | -193.75 Million USD | -86.279% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1002670.353% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1962.548% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10173.992% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 134.235% |
| Eyenovia, Inc. | 1.25 Million USD | 28774.406% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1441.48% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11029.366% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -985.588% |
| Arcellx, Inc. | -296.95 Million USD | -21.541% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1750.33% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -513.037% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1641.329% |
| Moolec Science SA | 117.61 Thousand USD | 306967.541% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -839.934% |
| Geron Corporation | 14.76 Million USD | 2545.128% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -851.858% |
| Royalty Pharma plc | 5.65 Billion USD | 106.379% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -155.213% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5063.878% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6630.092% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -156.465% |
| Humacyte, Inc. | -22.48 Million USD | -1505.111% |
| Structure Therapeutics Inc. | -124.33 Million USD | -190.275% |
| 89bio, Inc. | -289.05 Million USD | -24.865% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1329.86% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -20142.587% |
| Genelux Corporation | -6.89 Million USD | -5131.56% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1062.064% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 531.734% |
| Notable Labs, Ltd. | -9.77 Million USD | -3591.953% |
| Liquidia Corporation | -80.17 Million USD | -350.166% |
| Mustang Bio, Inc. | -3.73 Million USD | -9560.742% |
| Immunovant, Inc. | -635.22 Million USD | 43.182% |
| Quantum-Si incorporated | -118.55 Million USD | -204.432% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1954.915% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8611.69% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4596.391% |
| Acasti Pharma Inc. | -23 Million USD | -1468.899% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10618.764% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2121.165% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -162.034% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11481.624% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1523.45% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1843.698% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -113.215% |
| PepGen Inc. | -60.67 Million USD | -494.899% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1470.88% |
| United Therapeutics Corporation | -507.7 Million USD | 28.91% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1787.093% |
| Solid Biosciences Inc. | -47.75 Million USD | -655.865% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41766.365% |
| Immuneering Corporation | -54.94 Million USD | -556.91% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8486.329% |
| Silo Pharma, Inc. | -3.52 Million USD | -10141.027% |
| Belite Bio, Inc | -87.27 Million USD | -313.568% |
| XOMA Corporation | -29 Million USD | -1144.57% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -410.524% |
| Bionomics Limited | 227 Million USD | 258.991% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -210.388% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14148.927% |
| uniQure N.V. | -102.95 Million USD | -250.58% |
| Cassava Sciences, Inc. | -121.13 Million USD | -197.951% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8564.784% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 981.359% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2917.518% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11564.577% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 340595.592% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11029.366% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4153.064% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4766.846% |
| Altimmune, Inc. | -134.48 Million USD | -168.372% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 282.226% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14148.927% |
| Compugen Ltd. | -12.9 Million USD | -2697.003% |
| Peak Bio, Inc. | 10.34 Million USD | 3590.52% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -127435.451% |
| Benitec Biopharma Inc. | -50.58 Million USD | -613.545% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -245.919% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1937.238% |
| Zura Bio Limited | -99.8 Million USD | -261.627% |
| PolyPid Ltd. | 6.17 Million USD | 5949.681% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 586.947% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1937.238% |
| Instil Bio, Inc. | 75.35 Million USD | 578.948% |
| argenx SE | -2.02 Billion USD | 82.21% |
| Immunome, Inc. | -97.02 Million USD | -271.977% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1504.469% |
| Verona Pharma plc | -220.44 Million USD | -63.727% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -403.081% |
| Shattuck Labs, Inc. | -121.42 Million USD | -197.244% |
| CervoMed Inc. | -7.79 Million USD | -4531.496% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -94.57% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8153.495% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -173.968% |
| Moolec Science SA | 117.61 Thousand USD | 306967.541% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -15674.867% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2370.202% |
| AnaptysBio, Inc. | -18.15 Million USD | -1888.46% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1888.569% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -412.816% |
| NeurAxis, Inc. | 145.7 Thousand USD | 247818.138% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3313.367% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1166.716% |
| Achilles Therapeutics plc | -126.92 Million USD | -184.363% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -403.081% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -54941.759% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1637.404% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24852.667% |
| Nutriband Inc. | -251.65 Thousand USD | -143319.546% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2640.303% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4751.147% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 206.093% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1620.646% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 19.341% |
| Palisade Bio, Inc. | -12.06 Million USD | -2892.003% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -157.232% |
| Beam Therapeutics Inc. | -262.72 Million USD | -37.379% |
| Neurogene Inc. | -131.95 Million USD | -173.522% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1754.407% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7296.011% |
| Sesen Bio, Inc. | -112.55 Million USD | -220.671% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -261.431% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15272.962% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -824.833% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -333.377% |
| Athira Pharma, Inc. | -88.99 Million USD | -305.539% |
| Vaccinex, Inc. | -1.28 Million USD | -27922.153% |
| HCW Biologics Inc. | 2.85 Million USD | 12734.451% |
| XOMA Corporation | -29 Million USD | -1144.57% |
| Nektar Therapeutics | 210.24 Million USD | 271.673% |
| Arvinas, Inc. | -313.8 Million USD | -15.018% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22339.667% |
| Merus N.V. | -192.88 Million USD | -87.12% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 701.693% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5102.152% |
| Rezolute, Inc. | -68.16 Million USD | -429.464% |
| Clene Inc. | 3.34 Million USD | 10906.148% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2636.978% |
| BeyondSpring Inc. | -13.75 Million USD | -2523.957% |
| Synlogic, Inc. | -6.68 Million USD | -5299.033% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 31927.63% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4168.78% |
| Peak Bio, Inc. | 10.34 Million USD | 3590.52% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -337.91% |
| Krystal Biotech, Inc. | -350.23 Million USD | -3.053% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 390.776% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -113.57% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11332.02% |
| MannKind Corporation | 143.89 Million USD | 350.819% |
| Ikena Oncology, Inc. | -109.15 Million USD | -230.651% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4667.208% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -990.409% |
| Gossamer Bio, Inc. | 180.35 Million USD | 300.119% |
| CohBar, Inc. | -5.93 Million USD | -5985.68% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1113.276% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8004.628% |
| Legend Biotech Corporation | -949.39 Million USD | 61.984% |
| Mural Oncology plc | -255.84 Million USD | -41.073% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1220.364% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7561.914% |
| Disc Medicine, Inc. | -358.28 Million USD | -0.738% |
| Champions Oncology, Inc. | 4.81 Million USD | 7600.526% |
| REGENXBIO Inc. | 54.76 Million USD | 759.008% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -134119.387% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -138.985% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3904.939% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -347.338% |
| Vaxart, Inc. | -8.24 Million USD | -4279.63% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -619.262% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -183.823% |
| Cellectis S.A. | -43.85 Million USD | -722.997% |
| Longeveron Inc. | -2.9 Million USD | -12311.462% |
| Repare Therapeutics Inc. | -107.85 Million USD | -234.63% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 137.271% |
| Inozyme Pharma, Inc. | 12 Million USD | 3106.709% |
| Revolution Medicines, Inc. | -608.2 Million USD | 40.657% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -29243.523% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -36.138% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -140.501% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2206.674% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -48673.693% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.226% |
| Denali Therapeutics Inc. | -74.86 Million USD | -382.102% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2909.793% |
| Veru Inc. | 4.77 Million USD | 7650.788% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3109.366% |
| Cingulate Inc. | 3.08 Million USD | 11808.156% |
| Passage Bio, Inc. | 4.58 Million USD | 7971.872% |
| Context Therapeutics Inc. | -14.44 Million USD | -2397.783% |
| Exicure, Inc. | 5.84 Million USD | 6270.719% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -56.668% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -812.119% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2400.206% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -513.599% |
| Nuvalent, Inc. | -335.38 Million USD | -7.615% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 20910.517% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -384.581% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3959.902% |
| OmniAb, Inc. | 9.2 Million USD | 4021.823% |
| Anew Medical, Inc. | 1.43 Million USD | 25296.101% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2303.215% |
| Lipocine Inc. | -4.75 Million USD | -7491.089% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -228.628% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2469.676% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -612.46% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1549.965% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5270.113% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -448.294% |
| Ocugen, Inc. | -32.52 Million USD | -1009.822% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -321.765% |
| Q32 Bio Inc. | -37.94 Million USD | -851.105% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -57372.186% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2567.79% |
| Equillium, Inc. | -22.39 Million USD | -1511.849% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1311.629% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1006.225% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -145484.304% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 369.263% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11385.97% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 109990.46% |
| Dominari Holdings Inc. | 195 Thousand USD | 185189.911% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6752.696% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3947.609% |
| Bio-Techne Corporation | 267.74 Million USD | 234.801% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2126.697% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -205.625% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4195.196% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2752.939% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -47.245% |
| Nkarta, Inc. | 57.29 Million USD | 729.898% |
| BioCardia, Inc. | 212 Thousand USD | 170347.796% |
| Iterum Therapeutics plc | 13.43 Million USD | 2785.856% |